BBIO Operating Cash Flow (Statement)
Bridgebio Pharma Inc · Operating Cash Flow (Statement)
BBIO Operating Cash Flow (Statement)
Latest reported-$434.37Mperiod ending
BBIO TTM Cash from Operations (-$136.64M → -$434.37M)
TTM operating cash flow (statement)
High-resolution chart · PNG
BBIO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -434,374,000 | |
| -443,954,000 | |
| -445,910,000 | |
| -584,816,000 | |
| -655,808,000 | |
| -500,424,000 | |
| -520,726,000 | |
| -450,219,000 | |
| -414,879,000 | |
| -602,935,000 | |
| -527,720,000 | |
| -496,144,000 | |
| -486,081,000 | |
| -403,181,000 | |
| -419,494,000 | |
| -460,146,000 | |
| -446,544,000 | |
| -507,804,000 | |
| -497,934,000 | |
| -460,300,000 | |
| -470,423,000 | |
| -466,559,000 | |
| -399,714,000 | |
| -379,656,000 | |
| -297,968,000 | |
| -278,367,000 | |
| -253,587,000 | |
| -223,798,000 | |
| -212,124,000 | |
| -177,832,000 | |
| -136,643,000 |